Status:
NOT_YET_RECRUITING
Accuracy of Interstitial Continuous Glucose Sensors in Neonates
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Neonatal Hypoglycemia
Gestational Diabetes
Eligibility:
All Genders
Brief Summary
Low blood sugar in newborns is common and if prolonged or untreated may place them at increased risk for later learning and behavior challenges. Currently, we measure newborn glucose with at least fou...
Detailed Description
Glycemic control in newborns remains a major challenge for neonatal care. One third of U.S. infants are screened for neonatal hypoglycemia (NH) with repeated, painful heel sticks, most commonly based ...
Eligibility Criteria
Inclusion
- women aged 18 years or older
- speaks English, Spanish, Portuguese, or Haitian Creole
- pregnant \>24 weeks gestation with singleton pregnancy
Exclusion
- known concomitant maternal or fetal condition which, in the opinion of the investigator, could present a risk to the safety or welfare of the subject or study staff
- plans to deliver at a hospital other than Women and Infants Hospital of Rhode Island
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT07133906
Start Date
September 1 2025
End Date
June 1 2027
Last Update
August 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.